Goldman Sachs said today that it is maintaining its Charles River Laboratories CRL estimates, price target, and Neutral rating ahead of Tuesday's 2011 guidance call.
Charles River Laboratories currently trades at $33.91.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: Analyst RatingsCharles River LaboratoriesGoldman SachsHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
